Understanding when your blood sugar levels are higher than normal is essential for maintaining your health and preventing serious complications. Recognizing the signs early and knowing when to seek testing can make a significant difference in managing this condition effectively.
Introduction: Who Should Seek Diagnostics and When
If you experience frequent urination, excessive thirst, unexplained fatigue, or blurred vision, it may be time to consider getting tested for hyperglycemia, which means having too much glucose or sugar in your blood. These warning signs often appear gradually, building up over several days or weeks, which is why many people don’t realize something is wrong until their blood sugar has been elevated for quite some time.[1]
People with diabetes should monitor their blood sugar regularly because they are at constant risk of developing hyperglycemia. However, you don’t need to have diabetes to experience high blood sugar. Anyone who feels unusually thirsty, needs to urinate more often than usual, or feels persistently tired should talk to their doctor about testing. If you have a family history of type 2 diabetes, are overweight, lead a sedentary lifestyle, or belong to certain ethnic groups including Native Americans, Hispanics, Asian Americans, Pacific Islanders, or African Americans, you face a higher risk and should be especially vigilant.[3]
It’s particularly important to seek immediate medical attention if you develop more severe symptoms such as fruity-smelling breath, nausea and vomiting, abdominal pain, shortness of breath, confusion, or loss of consciousness. These can indicate a dangerous complication called diabetic ketoacidosis, which occurs when your body breaks down fat for energy because it cannot use glucose properly, producing harmful acids called ketones.[1]
Diagnostic Methods for Identifying Hyperglycemia
The primary way to diagnose hyperglycemia is through measuring blood glucose levels. For people without a prior diabetes diagnosis, hyperglycemia is defined as blood glucose greater than 125 mg/dL (milligrams per deciliter) when fasting, meaning you haven’t eaten for at least eight hours. After eating, hyperglycemia is generally considered to be blood glucose greater than 180 mg/dL measured two hours after a meal.[3]
There are several ways healthcare providers measure blood sugar to diagnose hyperglycemia. The most straightforward method involves taking a blood sample and analyzing it in a laboratory. This gives an accurate snapshot of your blood glucose level at that specific moment. However, because blood sugar fluctuates throughout the day depending on what you eat, your activity level, stress, and other factors, a single measurement may not tell the whole story.[11]
To understand your blood sugar patterns over time, doctors often recommend using a blood glucose meter at home. This small device measures the amount of sugar in a tiny sample of blood, usually obtained by pricking your fingertip with a small needle called a lancet. You place the drop of blood on a test strip that the meter reads within seconds. Many people with diabetes check their blood sugar several times a day using this method—typically when they first wake up, before meals, two hours after eating, and at bedtime.[15]
Another increasingly common tool is a continuous glucose monitor or CGM. This device uses a small sensor inserted under your skin that measures your blood sugar every few minutes throughout the day and night. The sensor sends information to a display device or smartphone app, allowing you to see how your blood sugar changes in real time without having to prick your finger repeatedly. Even if you use a CGM, you’ll still need to check your blood sugar with a traditional meter daily to make sure the CGM readings are accurate.[15]
When evaluating someone for diabetes or pre-diabetes, healthcare providers look at specific thresholds. A person has impaired glucose tolerance, also called pre-diabetes, if their fasting blood glucose falls between 100 mg/dL and 125 mg/dL. If fasting blood glucose exceeds 125 mg/dL on more than one occasion, this usually leads to a diagnosis of diabetes, most commonly type 2 diabetes. People with type 1 diabetes typically present with very high blood sugar levels, often above 250 mg/dL, at the time of diagnosis.[11]
Beyond measuring blood glucose directly, doctors may also order additional tests to understand the underlying cause of hyperglycemia or to check for complications. Blood tests can reveal how your kidneys and liver are functioning, measure electrolyte levels, and detect signs of infection or other conditions that might be causing or worsening high blood sugar.[3]
For people experiencing symptoms of diabetic ketoacidosis, testing for ketones becomes critical. Ketones are acids that build up in your blood when your body cannot use glucose for energy and breaks down fat instead. You can check for ketones using an over-the-counter urine test kit or a blood ketone meter. If your blood sugar is 240 mg/dL or higher, or if you’re feeling sick, you should test for ketones. High ketone levels indicate a medical emergency requiring immediate attention.[10]
Healthcare providers also use a test called A1C or hemoglobin A1C to assess long-term blood sugar control. This blood test shows your average blood glucose level over the past two to three months by measuring the percentage of your red blood cells that have glucose attached to them. Unlike a fasting blood glucose test that captures a single moment, the A1C provides a broader picture of how well blood sugar has been controlled over time.[10]
When diagnosing hyperglycemia, doctors must also rule out other conditions that can cause similar symptoms or contribute to high blood sugar. They will ask about your medical history, including any medications you’re taking, as certain drugs such as corticosteroids, thiazide diuretics, beta-blockers, and antipsychotics can raise blood glucose levels. They’ll also check for conditions affecting the pancreas or causing insulin resistance, such as Cushing’s syndrome or acromegaly.[4]
Diagnostics for Clinical Trial Qualification
When researchers design clinical trials for diabetes and hyperglycemia treatments, they establish specific diagnostic criteria to determine which patients can participate. These standardized tests ensure that all participants have similar baseline characteristics, making it easier to evaluate whether a new treatment works effectively and safely.
Clinical trials typically require documented evidence of hyperglycemia through repeated blood glucose measurements. Researchers often set specific thresholds that participants must meet, such as a fasting blood glucose above a certain level or an A1C percentage within a particular range. These measurements help identify people whose condition matches the severity level the study is designed to address. For instance, a trial testing a medication for type 2 diabetes might require participants to have fasting blood glucose consistently above 126 mg/dL or an A1C above 7.0%.[13]
Beyond basic glucose measurements, clinical trial protocols may require additional diagnostic tests to ensure participant safety and establish baseline health status. These can include kidney function tests to measure how well the kidneys are filtering waste, liver function tests to check for any pre-existing liver problems, and tests measuring cholesterol and triglyceride levels. Researchers need this comprehensive health information to monitor whether the experimental treatment causes any unexpected effects on other organ systems.[13]
Some trials specifically studying complications of hyperglycemia, such as those affecting the eyes, kidneys, nerves, or heart, require specialized diagnostic procedures before enrollment. For example, a study examining treatments for diabetic kidney disease would require tests showing evidence of kidney damage, such as elevated protein levels in the urine or decreased kidney filtration rates. Similarly, trials for diabetic nerve damage might require nerve conduction studies demonstrating impaired nerve function.[3]
Continuous glucose monitoring data is increasingly being used in clinical trials as both a qualifying diagnostic tool and an outcome measure. Researchers can review CGM data to see detailed patterns of blood sugar fluctuations over days or weeks, identifying participants who experience frequent episodes of hyperglycemia despite current treatment. This technology allows for more precise selection of trial participants and more accurate assessment of how well new treatments control blood sugar throughout the day and night.



